Dr. C.G. Wang is the Chief Technology Officer of C9 Corporation. Trained as a physicist, Dr.Wang is an inventor-entrepreneur and president of NanoDynamics-88, Inc., an R&D company focused on device physics and supported mainly by defense contracts and awards. He also heads Profile Diagnostics Sciences, Inc. a biomedical company which conducts research on major diseases and is funded by the federal government. CG Wang participated in the building of the first American satellites, studied under S. Chandrasekhar, earned a Ph.D. at Cornell University, worked post doctorate under Hans Bethe and solved the Bethe-Goldstone equation. He taught physics at MIT and did research in astrophysics. He created three of the nine known methods of isotope enrichment and the current novel approach of silicon carbide fabrication. They are the core patented products for C9. Working together with the staff of Nanodynamics-88 and C9 Corporation, Dr. Wang will be responsible for technology development.

Mr. Kevin Donegan is the CEO and president of C9 Corporation. Trained as an engineer, Donegan has been lecturing on the uses of silicon carbide at commercial and military conferences since 1996. He led a composite team for SAIC, Northrop Grumman, United Defense and Satcon for the DARPA CHPS (Combat Hybrid Power System) program starting in 1997. As an expert in power conversion topologies and semiconductor device applications, he holds 15 patents with more pending. He is also CEO of Amtrade, which brings military R&D technologies to the commercial market. Amtrade has designed and issued proposals for converter platforms up to the megawatt class for corporate clients. Previously, he was a vice president at Silicon Power Corporation, where he led the development and marketing of five product lines. He has also held management, engineering and sales positions at R&D companies focused on technologies such as sonar and laser.